1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Reduction in Volume of Nucleus Basalis of Meynert Is Specific to Parkinson’s Disease and Progressive Supranuclear Palsy but Not to Multiple System Atrophy
(
- Contribution to journal › Article
- 2021
-
Mark
A Modified Progressive Supranuclear Palsy Rating Scale
(
- Contribution to journal › Article
- 2020
-
Mark
Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies
(
- Contribution to journal › Article
-
Mark
Clinical Conditions “Suggestive of Progressive Supranuclear Palsy”—Diagnostic Performance
(
- Contribution to journal › Article
- 2017
-
Mark
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
(
- Contribution to journal › Scientific review
-
Mark
Clinical diagnosis of progressive supranuclear palsy : The movement disorder society criteria
(
- Contribution to journal › Article
- 2016
-
Mark
A genome-wide association study in multiple system atrophy
(
- Contribution to journal › Article
-
Mark
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
(
- Contribution to journal › Article
- 2011
-
Mark
Systemic administration of Neuregulin-1ß(1) protects dopaminergic neurons in a mouse model of Parkinson's disease.
(
- Contribution to journal › Article